(Q45236152)

11 December 2017

title

Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction (English)

1 reference

11 December 2017

1 reference

3

1 reference

11 December 2017

Soldatos G

1

1 reference

11 December 2017

Sztal-Mazer S

series ordinal

2

1 reference

11 December 2017

Stockigt J

series ordinal

4

1 reference

11 December 2017

publication date

1 January 2005

1 reference

Internal Medicine Journal

11 December 2017

published in

1 reference

11 December 2017

volume

35

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

67-68

1 reference

Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00723.X

Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00723.X

Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00723.X

Cushing's syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00723.X

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00723.X

Budesonide-induced acute hepatitis in an HIV-positive patient with ritonavir as a co-medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2004.00723.X

10.1111/J.1445-5994.2004.00723.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference